steady state for modified release [Regulatives / Guidelines]

posted by Kelen – Brazil, 2019-09-20 20:04 (759 d 13:48 ago) – Posting: # 20636
Views: 4,319

I would like to ask help for understand the objetive of the steady state study when you are comparing a MR formulation with a IR formulation. The objective would be compare the effect of the accumulation? Is there any reason to conduct the study only with de highest dose?


Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Admin contact
21,738 posts in 4,546 threads, 1,543 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Tuesday 09:52 CEST (Europe/Vienna)

Sometimes the key to an answer is found
in the way you formulate the question.    David Brin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5